CHARR peer analysis
CHARR (CHARR) against its competitors: price, today's move, 1-year return and market value side by side.
- CHARR's peers: BENF (Beneficient), CHPG (ChampionsGate Acquisition), CLDI (Calidi Biotherapeutics), LCCC (Lakeshore Acquisition), ORIQW (Origin Investment Corp I Warrant.), PGAC (Pantages Capital Acquisition), RMCO (Royalty Management), SSEAR (Starry Sea Acquisition Corp Rights).
CHARR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BENF Beneficient | $0.48 | -8.69% | -89.48% | $7.37M |
| CHPG ChampionsGate Acquisition | $10.54 | 0.09% | – | $105.27M |
| CLDI Calidi Biotherapeutics | $0.51 | -4.23% | -97.88% | $1.74M |
| LCCC Lakeshore Acquisition | $10.55 | -0.09% | – | – |
| ORIQW Origin Investment Corp I Warrant. | $0.14 | 0.00% | – | $1.31M |
| PGAC Pantages Capital Acquisition | $10.87 | -0.09% | – | $55.83M |
| RMCO Royalty Management | $2.06 | -5.07% | -33.23% | $31.29M |
| SSEAR Starry Sea Acquisition Corp Rights | $0.07 | 0.00% | – | $80.41M |
| CHARR Charlton Aria Acquisition | $0.15 | -15.95% | – | $1.62M |